Calithera Biosciences Reports Second Quarter 2022 Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Struggling Calithera nabs 2 cheap cancer assets from Takeda
20 Oct 2021 //
THEPHARMALETTER
Slammed with PhII flop for lead drug, Calithera lays off a third of its staffers
05 Jan 2021 //
ENDPTS
Calithera Announces Expansion of Ongoing Trial Evaluating Telaglenastat
04 Nov 2020 //
GLOBENEWSWIRE
Calithera Biosc`s Completes Pt Enrollment in Ph 2 Telaglenastat + Everolimus
06 Feb 2019 //
GLOBENEWSWIRE